Literature DB >> 30064996

The Clock Protein Bmal1 Regulates Circadian Expression and Activity of Sulfotransferase 1a1 in Mice.

Lianxia Guo1, Fangjun Yu1, Tianpeng Zhang1, Baojian Wu2.   

Abstract

Sulfotransferase 1a1 (Sult1a1) is a phase II enzyme that contributes extensively to metabolism and detoxification of various drugs and chemicals. Here we aimed to investigate a potential role of the clock protein Bmal1 (brain and muscle Arnt-like protein-1) in circadian regulation of Sult1a1 in mice. The regulatory effects of Bmal1 on Sult1a1 were assessed both in vivo (using Bmal1- deficient mice) and in vitro (using both normal and serum-shocked Hepa-1c1c7 cells). The relative mRNA and protein levels of Sult1a1 in the cells or mouse livers were measured by RT-qPCR and Western blotting, respectively. Sulfation activities of two Sult1a1 substrates (i.e., p-nitrophenol and galangin) were determined using mouse liver S9 fractions. Transcriptional regulation of Sult1a1 by Bmal1 was investigated using luciferase reporter, electrophoretic mobility shift (EMSA), and chromatin immunoprecipitation (ChIP) assays. We first showed that hepatic Sult1a1 was rhythmically expressed at both mRNA and protein levels (higher expressions during the night than the daytime). Consistently, the liver sulfation activities toward two Sult1a1 substrates were circadian time dependent with a higher activity at ZT14 than at ZT2. Furthermore, deletion of Bmal1 in mice blunted the circadian rhythmicity of hepatic Sult1a1 (with reduced expression levels). Likewise, Bmal1 positively regulated Sult1a1 expression in conventionally cultured Hepa-1c1c7 cells, and Bmal1 knockdown blunted expression rhythmicity of Sult1a1 in serum-shocked Hepa-1c1c7 cells. A combination of promoter analysis, EMSA and ChIP assays revealed that Bmal1 stimulated Sult1a1 transcription through its specific binding to the-571- to -554-bp region (an E-box element) in the promoter. In conclusion, Bmal1 activated the transcription of Sult1a1 and controlled circadian expression and activity of the enzyme.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30064996     DOI: 10.1124/dmd.118.082503

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

1.  Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice.

Authors:  Yanke Lin; Shuai Wang; Ziyue Zhou; Lianxia Guo; Fangjun Yu; Baojian Wu
Journal:  Commun Biol       Date:  2019-10-16

2.  Circadian Clock Gene Bmal1 Regulates Bilirubin Detoxification: A Potential Mechanism of Feedback Control of Hyperbilirubinemia.

Authors:  Shuai Wang; Yanke Lin; Ziyue Zhou; Lu Gao; Zemin Yang; Feng Li; Baojian Wu
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

3.  Integrative analysis of transcriptomic data related to the liver of laying hens: from physiological basics to newly identified functions.

Authors:  Audrey Gloux; Michel J Duclos; Aurélien Brionne; Marie Bourin; Yves Nys; Sophie Réhault-Godbert
Journal:  BMC Genomics       Date:  2019-11-07       Impact factor: 3.969

4.  Low dose of luteolin activates Nrf2 in the liver of mice at start of the active phase but not that of the inactive phase.

Authors:  Tomoya Kitakaze; Atsushi Makiyama; Yoko Yamashita; Hitoshi Ashida
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

5.  Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle.

Authors:  Yool Lee; Shi Yi Fong; Joy Shon; Shirley L Zhang; Rebekah Brooks; Nicholas F Lahens; Dechun Chen; Chi Van Dang; Jeffrey M Field; Amita Sehgal
Journal:  Sci Adv       Date:  2021-02-12       Impact factor: 14.136

Review 6.  Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-04-01       Impact factor: 2.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.